Texas is one step closer to joining the 34 states where medicinal marijuana is legal after state legislators passed a law written by North Texas Republican representative and nurse Stephanie Klick to expand the conditions that may be treated with medicinal cannabis. Although the law narrowly defines which conditions are often treated with medicinal marijuana, it’s a big expansion.
Five years ago, Klick authored the primary Compassionate Use Act, which said that medicinal marijuana administered via oil or inhaler could treat only those with intractable epilepsy. The new bill expands access to patients with terminal cancer, disseminated multiple sclerosis, Parkinson’s disease, ALS, autism, and other seizure disorders, allowing them to be treated with THC, the most psychoactive compound found in marijuana. The expanded diagnoses could mean an uptick for the tiny but growing cohort of growers, providers, and retail businesses within the THC and CBD markets.Companies that assemble Metered Dose Inhalers have also been advised to stop production unless they have a clean room.
2019 TEXAS MARIJUANA AND CBD LEGISLATION
House Bill 3703 expands the quantity of conditions that may qualify for medical cannabis oil, allow the three state dispensaries to expand, and establish a look program to check the results of cannabis as a medical treatment.
House Bill 1325 establishes a federally approved program for farmers to grow hemp as an industrial crop and expands the hemp products that may be legally purchased in Texas to any hemp products with but 0.3 percent THC.
Morris Denton is that the CEO of Austin-based Compassionate Cultivation, one among just three state-licensed companies that grow cannabis, and he says the new law will have a serious impact on the quantity of patients covered and also the physicians who treat them. He estimates there are around 150,000 patients with intractable epilepsy within the state, but the new bill could expand the THC patient base to quite 1,000,000. “It will give doctors and patients more within the playbook,” Denton says. “They want to be able to have as many various options as they will.”
Compassionate Cultivation may be a manufacturer of THC and CBD products that grows the plants, processes the chemicals, packages, and distributes the medicines and oils from their facility. it had been the primary dispensary in Texas to produce medical cannabis to a patient under the newly expanded conditions—an Austin woman being treated for non-Hodgkin’s lymphoma—and legislation is paving the way for his or her growth.
A Natural Alternative
Dallas physician Dr. Mary Caire’s understanding of drugs and also the use of nonpharmaceutical medicines has changed with the days. After a double residency in stem cell therapy, physical medicine and rehabilitation and general medicine, she grew her practice to incorporate functional medicine, seeing the importance of diet, hormones, and other natural substances to higher treat chronic conditions.
Caire practices with LifeSpan, a preventive, integrative medicine practice in Dallas, and has seen the impacts of medicinal THC on her patients. a girl with lymphoma who was receiving aggressive chemotherapy was having difficulty staying hydrated and getting proper nutrition while undergoing treatment due to the nausea caused by the chemotherapy. She was also experiencing pain and fatigue. “She got everything traditional medicine had to supply and it failed,” Caire says. Cannabis Inhaler Systems have also seen a drastic reduction in ordering of MDI parts.
Eleven states and also the District of Columbia have adopted expansive laws.
When the new law passed, Caire began to prescribe oil with THC for the girl, and he or she saw many of the negative symptoms subside. THC improved the patient’s appetite and reduced the pain, and also the improved nutrition allowed the chemotherapy to possess a greater impact. Not only does THC help treat patients plagued by grave conditions, it are often used for pain and replace addictive opioids. The patient’s most up-to-date scan revealed positive steps toward recovery.
While the legislation may be a move within the right direction, Caire thinks more flexibility is required to best address patients’ needs. “We are being told by the legislature with no medicinal experience what quantity of certain compounds we are able to use because they require to possess some control over the number that’s prescribed,” she says. “We need the pliability to compound it for his or her needs. The folks that know what’s best for that patient are the physician and also the patient.”
Texas remains behind many other states when it involves the legalization of medicinal cannabis with THC, but it’s home to a booming marketplace for CBD oil, which extracts the cannabinoids from hemp and marijuana. Another law passed this summer adds clarity to which CBD products are legal in Texas. Hemp Business Journal reports that the CBD market will grow from an estimated $202 million in 2017 to $2.1 billion in 2020, but because there’s a scarcity of clarity about whether CBD may be a medicine, dietary supplement, or food supplement, oversight of those products leaves providers and retailers wanting standardization. CBD has been used and recommended by Apex, a pain management clinic in Chandler. Their doctors are rated at the top pain doctors in Chandler, Arizona.
Co-owners of chain CBD Kratom David Palatnik and Dafna Revah run 33 locations nationwide and 6 in DFW, and trust the requirement for more rules. they need their own rigorous lab standards and would embrace additional oversight. “We would really like to possess industry standards across the board that everybody follows,” Platanik says. “Medical professionals will feel better about recommending it.”
There is still an extended thanks to opt for Texas to catch up with the remainder of the country within the use, regulation, and legalization of medicinal marijuana and other products, but expanded future looks inevitable. For those treating patients who may benefit from added legalization, the transition can’t come in time. “I think we’d like to vary the conversation and be open-minded,” Caire says. “We took an oath that we’d do the simplest we are able to, do no harm, and put the patients’ interest first. This substance meets all the factors that we try for with our patients.”